Board Meeting3 Nov 2026, 04:21 pm
Bal Pharma Board Meeting on Nov 11, 2026 for Q2 Results
AI Summary
Bal Pharma Ltd has announced that its Board of Directors will convene on November 11, 2026. The primary agenda item for this meeting is the consideration and approval of the unaudited standalone and consolidated financial results for the second quarter and half-year ended September 30, 2026. The meeting will also address any other necessary matters as permitted by the Chair, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Board meeting scheduled for November 11, 2026.
- To consider and approve unaudited financial results.
- Results will be for Q2 and half-year ended September 30, 2026.
- Compliance with SEBI LODR regulations confirmed.
Price Impact
More from BALPHARMA